99% Savings - Buy Just @1 Rs X
Bladmir S Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Bladmir S Tablet safe for pregnant women?
Bladmir S Tablet can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Bladmir S Tablet right away. Take your doctor's advice before taking it again.
Is the use of Bladmir S Tablet safe during breastfeeding?
Bladmir S Tablet may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Bladmir S Tablet, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Bladmir S Tablet.
What is the effect of Bladmir S Tablet on the Kidneys?
Bladmir S Tablet has very mild side effects on the kidneys.
What is the effect of Bladmir S Tablet on the Liver?
Bladmir S Tablet is rarely harmful for the liver.
What is the effect of Bladmir S Tablet on the Heart?
Very few cases of side effects of Bladmir S Tablet on the heart have been reported.
Bladmir S Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Bladmir S Tablet unless your doctor advises you to do so -
Is this Bladmir S Tablet habit forming or addictive?
No, you will not get addicted to Bladmir S Tablet .
Interaction between Food and Bladmir S Tablet
Taking Bladmir S Tablet with food is safe.
Interaction between Alcohol and Bladmir S Tablet
Consumption of alcohol and Bladmir S Tablet together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 864
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Myrbetriq (mirabegron)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Betmiga® (mirabegron)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; VESIcare® (solifenacin succinate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1151